Company intelligence / Profile preview

EDX Medical Group

Cambridge, England, United Kingdomedxmedical.co.uk ↗

Ownership: Private
Development stage: Commercial

Overview

EDX Medical offers a suite of CE-marked/commercially available diagnostic tests in oncology, cardiology, and infectious diseases. Their Cambridge-based lab is UKAS-accredited to ISO 15189 standards. They have launched new comprehensive screening tests for prostate cancer (“super test”) and early detection of testicular cancer.

Therapeutic areas: OncologyCardiovascularMetabolic Disorders
Modalities: Diagnostic testNext-generation sequencing (NGS)Genomic profiling
Industry: Molecular Diagnostics

Partnerships

Caris Life SciencesCuresponse

Beyond the preview

Go deeper on EDX Medical Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EDX Medical Group.

Explore the full profile